Skip to main content

Table 1 Site-specific burden of cancer (YLLs, YLDs, DALYs) per 100,000 by sex in 2016

From: Burden of cancers in India - estimates of cancer crude incidence, YLLs, YLDs and DALYs for 2021 and 2025 based on National Cancer Registry Program

ICD-10 Cancer site YLLs-ASR YLDs-ASR DALYs-ASR % YLLs to DALYs
Males Females Total Males Females Total Males Females Total
C00 Lip 3.5 1.7 2.6 0.5 0.2 0.3 3.9 1.9 2.9 88.3
C01-C02 Tongue 61.4 20.8 41.1 5.7 2.0 3.9 67.2 22.8 45.0 91.4
C03-C06 Mouth 81.6 34.1 57.8 8.0 3.4 5.7 89.6 37.4 63.5 91.0
C07-C08 Salivary Gland 3.7 2.0 2.9 0.8 0.7 0.8 4.5 2.7 3.6 79.0
C09 Tonsil 11.8 2.1 6.9 1.1 0.3 0.7 13.0 2.3 7.7 90.7
C10 Other Oropharynx 12.4 2.1 7.2 0.9 0.2 0.6 13.3 2.3 7.8 92.6
C11 Nasopharynx 7.9 3.3 5.6 0.7 0.4 0.5 8.6 3.6 6.1 91.7
C12-C13 Hypopharynx 29.8 7.9 18.8 2.7 0.6 1.7 32.5 8.5 20.5 91.9
C14 Pharynx Unspecified 11.3 3.5 7.4 0.5 0.2 0.3 11.8 3.6 7.7 95.5
C15 Oesophagus 84.3 44.3 64.3 5.1 3.1 4.1 89.4 47.4 68.4 94.0
C16 Stomach 72.3 41.9 57.1 4.4 2.4 3.4 76.7 44.3 60.5 94.4
C17 Small Intestine 3.6 2.6 3.1 0.3 0.2 0.3 3.9 2.9 3.4 91.9
C18 Colon 31.1 25.6 28.4 2.9 2.2 2.5 34.0 27.8 30.9 91.8
C19-C20 Rectum 29.8 21.4 25.6 2.8 1.9 2.4 32.6 23.4 28.0 91.6
C21 Anus and Anal cavity 3.9 2.9 3.4 0.5 0.3 0.4 4.3 3.2 3.8 89.3
C22 Liver 71.5 32.6 52.1 3.4 1.5 2.4 74.9 34.1 54.5 95.6
C23-C24 Gallbladder 29.4 54.7 42.1 2.1 3.6 2.8 31.5 58.3 44.9 93.7
C25 Pancreas 29.4 20.6 25.0 1.6 1.1 1.3 31.0 21.7 26.4 95.0
C30-C31 Nose, Sinuses 4.0 1.9 3.0 0.5 0.4 0.4 4.4 2.3 3.4 87.7
C32 Larynx 38.8 5.6 22.2 4.2 0.6 2.4 43.0 6.2 24.6 90.2
C33-C34 Lung 173.5 70.3 121.9 9.8 3.8 6.8 183.3 74.1 128.7 94.7
C37-C38 Other Thoracic Organs 4.0 2.7 3.3 0.3 0.2 0.2 4.2 2.8 3.5 93.7
C40-C41 Bone 13.8 10.2 12.0 1.1 0.8 1.0 14.9 11.0 12.9 92.6
C43 Melanoma of Skin 2.3 1.7 2.0 0.5 0.5 0.5 2.8 2.2 2.5 80.9
C44 Other Skin 9.1 6.9 8.0 1.3 1.3 1.3 10.5 8.2 9.3 86.0
C45 Mesothelioma 0.2 0.1 0.2 0.1 0.1 0.1 0.3 0.2 0.2 63.6
C46 Kaposi Sarcoma 0.2 0.3 0.2 0.0 0.2 0.1 0.2 0.5 0.3 62.0
C47 + C49 Connective & Soft Tissue 8.8 7.3 8.0 1.1 1.0 1.1 10.0 8.2 9.1 88.4
C50 Breast 5.7 203.6 104.6 0.8 29.1 15.0 6.5 232.7 119.6 87.5
C51 Vulva 0.0 2.4 1.2 0.0 0.4 0.2 0.0 2.8 1.4 85.0
C52 Vagina 0.0 3.2 1.6 0.0 0.5 0.3 0.0 3.7 1.9 86.2
C53 Cervix Uteri 0.0 87.6 43.8 0.0 11.0 5.5 0.0 98.6 49.3 88.9
C54 Corpus Uteri 0.0 14.9 7.5 0.0 3.9 1.9 0.0 18.8 9.4 79.4
C55 Uterus Unspecified 0.0 7.8 3.9 0.0 0.6 0.3 0.0 8.4 4.2 93.4
C56 Ovary 0.0 72.9 36.5 0.0 5.9 3.0 0.0 78.9 39.4 92.5
C57 Other Female Genital organs 0.0 0.6 0.3 0.0 0.1 0.1 0.0 0.7 0.4 84.1
C58 Placenta 0.0 0.3 0.2 0.0 0.7 0.4 0.0 1.1 0.5 31.0
C60 Penis 5.5 0.0 2.7 0.9 0.0 0.4 6.4 0.0 3.2 86.0
C61 Prostate 40.3 0.0 20.2 6.5 0.0 3.3 46.9 0.0 23.4 86.0
C62 Testis 4.5 0.0 2.3 0.6 0.0 0.3 5.1 0.0 2.6 88.7
C63 Other Male Genital organs 0.4 0.0 0.2 0.2 0.0 0.1 0.6 0.0 0.3 66.5
C64 Kidney 16.6 7.3 12.0 1.8 0.8 1.3 18.4 8.1 13.3 90.1
C65 Renal Pelvis 0.2 0.1 0.1 0.1 0.2 0.1 0.3 0.3 0.3 50.8
C66 Ureter 0.2 0.1 0.2 0.1 0.1 0.1 0.3 0.2 0.3 63.0
C67 Bladder 21.3 6.0 13.6 3.5 0.9 2.2 24.8 6.9 15.8 86.1
C68 Unspecified Urinary Organs 0.7 0.2 0.5 0.1 0.1 0.1 0.8 0.3 0.6 84.4
C69 Eye 1.5 0.8 1.2 0.4 0.5 0.4 1.9 1.3 1.6 72.8
C70-C72 Brain, Nervous System 37.7 26.1 31.9 2.2 1.5 1.9 39.9 27.6 33.7 94.5
C73 Thyroid 5.2 9.3 7.2 4.1 3.7 3.9 9.3 13.0 11.1 65.1
C74 Adrenal Gland 1.2 1.0 1.1 0.4 0.2 0.3 1.7 1.2 1.4 77.6
C81 Hodgkin’s Disease 7.5 4.5 6.0 1.0 0.6 0.8 8.5 5.1 6.8 88.6
C82-C85 Non-Hodgkin's Lymphoma 38.9 24.1 31.5 2.9 1.9 2.4 41.8 26.0 33.9 92.9
C88 Malignant Immunoproliferative Diseases 0.3 0.3 0.3 0.04 0.00 0.0 0.3 0.3 0.3 93.7
C90 Multiple Myeloma 15.5 12.8 14.1 1.4 1.1 1.2 16.9 13.8 15.4 92.0
C91 Lymphoid Leukaemia. 30.8 20.7 25.7 1.8 0.9 1.3 32.5 21.6 27.1 95.0
C92-C94 Myeloid Leukaemia 38.8 31.6 35.2 1.8 1.3 1.5 40.6 32.9 36.7 95.9
C95 Leukaemia Unspecified 14.7 10.8 12.8 0.4 0.4 0.4 15.1 11.2 13.2 97.0
C96 CMD, O&U LHM 1.3 0.8 1.0 0.1 0.1 0.1 1.4 0.9 1.1 91.3
O&Ua Other and unspecified 141.6 113.6 127.6 6.0 4.3 5.1 147.6 117.8 132.7 96.1
All cancer sites 1268.5 1097.4 1183.0 91.8 98.3 95.1 1360.39 1195.8 1278.1 92.6
  1. aO&U includes the Sites (ICD-10:C26, C39, C48, C75, C76, C77, C78, C79, C80, C97)
  2. CMD Chronic Myeloproliferative Disease, O&U LHM Other and unspecified malignant neoplasms of lymphoid, hematopoietic and related tissue